Vir Biotechnology (VIR) Other Non-Current Assets (2018 - 2026)

Vir Biotechnology (VIR) has 9 years of Other Non-Current Assets data on file, last reported at $7.0 million in Q1 2026.

• For the quarter ending Q1 2026, Other Non-Current Assets rose 10.89% year-over-year to $7.0 million; the trailing twelve-month figure through Mar 2026 stood at $7.0 million (up 10.89% YoY), and the FY2025 full-year result was $24.7 million, up 288.17% from the prior year.
• Other Non-Current Assets slipped to $7.0 million in Q1 2026, from $24.7 million in the prior quarter.
• In the past five years, Other Non-Current Assets ranged from a high of $24.7 million in Q4 2025 to a low of $6.3 million in Q1 2025.
• A 5-year average of $8.5 million and a median of $6.7 million in 2023 frame the typical range for Other Non-Current Assets.
• Across the five-year window, Other Non-Current Assets slipped 25.45% in 2023 and jumped 288.17% in 2025, its largest moves.
• Tracing VIR's Other Non-Current Assets over 5 years: stood at $6.7 million in 2022, then fell by 3.12% to $6.4 million in 2023, then decreased by 1.32% to $6.4 million in 2024, then jumped by 288.17% to $24.7 million in 2025, then sank by 71.84% to $7.0 million in 2026.
• Business Quant data shows VIR's Other Non-Current Assets at $7.0 million in Q1 2026, $24.7 million in Q4 2025, and $16.0 million in Q3 2025.